NasdaqCM - Nasdaq Real Time Price USD
Monopar Therapeutics Inc. (MNPR)
At close: 4:00 PM EST
After hours: 5:34 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
7,490.16
8,831.24
10,536.88
9,127.25
6,508.88
Operating Income
-7,490.16
-8,831.24
-10,536.88
-9,127.25
-6,508.88
Net Non Operating Interest Income Expense
365.97
429.04
21.24
24.02
81.90
Other Income Expense
--
--
--
--
122.40
Pretax Income
-7,124.18
-8,402.20
-10,515.64
-9,103.22
-6,304.57
Net Income Common Stockholders
-7,124.18
-8,402.20
-10,515.64
-9,103.22
-6,304.57
Diluted NI Available to Com Stockholders
-7,124.18
-8,402.20
-10,515.64
-9,103.22
-6,304.57
Basic EPS
-2.30
-3.05
-4.15
-3.65
-2.90
Diluted EPS
-2.30
-3.05
-4.15
-3.65
-2.90
Basic Average Shares
3,113.13
2,764.79
2,543.63
2,494.24
2,191.65
Diluted Average Shares
3,113.13
2,764.79
2,543.63
2,494.24
2,191.65
Total Operating Income as Reported
-7,490.16
-8,831.24
-10,536.88
-9,127.25
-6,508.88
Total Expenses
7,490.16
8,831.24
10,536.88
9,127.25
6,508.88
Net Income from Continuing & Discontinued Operation
-7,124.18
-8,402.20
-10,515.64
-9,103.22
-6,304.57
Normalized Income
-7,124.18
-8,402.20
-10,515.64
-9,103.22
-6,426.97
Interest Income
365.97
429.04
21.24
24.02
81.90
Net Interest Income
365.97
429.04
21.24
24.02
81.90
EBIT
-7,490.16
-8,831.24
-10,536.88
-9,127.25
-6,508.88
EBITDA
-7,490.16
-8,831.24
-10,536.88
-9,127.25
-6,508.88
Net Income from Continuing Operation Net Minority Interest
-7,124.18
-8,402.20
-10,515.64
-9,103.22
-6,304.57
Total Unusual Items Excluding Goodwill
--
--
--
--
122.40
Total Unusual Items
--
--
--
--
122.40
Normalized EBITDA
-7,490.16
-8,831.24
-10,536.88
-9,127.25
-6,631.28
Tax Rate for Calcs
--
0.00
0.00
--
--
12/31/2020 - 12/19/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GNPX Genprex, Inc.
1.5500
-14.36%
GRI GRI Bio, Inc.
0.9500
-4.04%
THAR Tharimmune, Inc.
2.8000
+1.08%
TVGN Tevogen Bio Holdings Inc.
1.3000
-24.42%
ZVSA ZyVersa Therapeutics, Inc.
1.5400
-39.37%
DRUG Bright Minds Biosciences Inc.
55.77
+3.12%
ENSC Ensysce Biosciences, Inc.
0.5503
+5.42%
TOVX Theriva Biologics, Inc.
1.9700
0.00%
BNOX Bionomics Limited
0.2789
-43.43%
GLUE Monte Rosa Therapeutics, Inc.
9.45
+0.96%